About: Vaporized H2O2 decontamination against surrogate viruses for the reuse of N95 respirators in the COVID-19 emergency

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Vaporized H2O2 decontamination against surrogate viruses for the reuse of N95 respirators in the COVID-19 emergency Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : wasabi.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	Vaporized H2O2 decontamination against surrogate viruses for the reuse of N95 respirators in the COVID-19 emergency
Creator	Budzilowicz, Amanda Collins, Cassidy Connolly, Rachel Durkin, John Gardecki, Joseph Gjore, Julian Jaber, Tareq Jones, Ralph Leung, Hui Muratoglu, Orhun Oral, Ebru Wannomae, Keith
Source	MedRxiv
abstract	Decontamination of N95 respirators has become critical to alleviate PPE shortages for healthcare workers in the current COVID-19 emergency. The factors that are considered for the effective reuse of these masks are the fit, filter efficiency and decontamination/disinfection level both for SARS-CoV-2, which is the causative virus for COVID-19, and for other organisms of concern in the hospital environment such as Staphylococcus aureus or Clostridium difficile. In its guidance entitled 'Recommendations for Sponsors Requesting EUAs for Decontamination and Bioburden Reduction Systems for Surgical Masks and Respirators During the Coronavirus Disease 2019 (COVID19) Public Health Emergency' (May 2020)[1], the FDA recommends a 6-log10 reduction in either the most resistant bacterial spores for the system or in a mycobacterium species to authorize the use of a decontamination method of N95 respirators for single or multiple users. While the goal is primarily inactivation against SARS-CoV-2, testing of decontamination methods against the virus may not always be available. For decontamination methods considered for only single users, the recommendation is a 6-log10 reduction in the infective virus concentration of 3 non-enveloped viruses or in the concentration of two Gram (+) and two Gram (-) bacteria. Based on these recommendations, we explored the efficacy of vaporized H2O2 (VHP) treatment of N95 respirators against surrogate viruses covering a wide range of disinfection resistance for emergency decontamination and reuse to alleviate PPE shortages for healthcare workers in the COVID-19 emergency.
has issue date	2020-06-28(xsd:dateTime)
bibo:doi	10.1101/2020.06.25.20140269
has license	medrxiv
sha1sum (hex)	10fd1ed5e9e4ee5ad39270ed5c09c91469ec41fb
schema:url	https://doi.org/10.1101/2020.06.25.20140269
resource representing a document's title	Vaporized H2O2 decontamination against surrogate viruses for the reuse of N95 respirators in the COVID-19 emergency
resource representing a document's body	covid:10fd1ed5e9e4ee5ad39270ed5c09c91469ec41fb#body_text
is schema:about of	named entity 'COVID-19' named entity 'respirators' named entity 'SURROGATE' named entity 'Clostridium' named entity 'PPE' named entity 'hospital' named entity 'decontamination' named entity 'reuse' named entity 'disinfection' named entity 'Staphylococcus aureus' named entity 'Decontamination' named entity 'COVID' named entity 'Clostridium difficile' named entity 'virus' named entity 'cytotoxic' named entity 'Needham Heights' named entity 'disinfection' named entity 'disinfection' named entity 'bioburden' named entity 'viruses' named entity 'biosafety cabinet' named entity 'biosafety cabinet' named entity 'titer' named entity 'cell culture medium' named entity 'infectivity' named entity 'cell culture medium' named entity 'bioburden' named entity 'cytotoxic' named entity 'respirator' named entity 'cell line' named entity 'cell culture media' named entity 'centrifugation' named entity 'respirator' named entity 'virus' named entity 'Steris' named entity 'FDA' named entity 'BVDV' named entity 'virus' named entity 'RPMI' named entity 'preprint' named entity 'BVDV' named entity 'viral titers' named entity 'cell culture medium' named entity 'EUAs' named entity 'preprint' named entity 'VHP' named entity 'virus' named entity 'virus' named entity 'BVDV' named entity 'Bacterial spore' named entity 'Public Health Emergency' named entity 'Surgical Masks' named entity 'FDA' named entity 'African green monkey kidney cells' named entity 'sterilization' named entity 'bacterial spores' named entity 'virus' named entity 'MDCK' named entity 'virus' named entity 'viruses' named entity 'N95' named entity 'virus' named entity 'N95' named entity 'biological safety cabinet' named entity 'RNA viruses' named entity 'medRxiv' named entity 'microtiter plates' named entity 'virus' named entity 'virus' named entity 'C. difficile' named entity 'COVID-19' named entity 'respirator' named entity 'virus' named entity 'virus'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software